Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/30/26 19:24 | 6/26/26 | GALT | Health | Drug | Pharmaceutical Preparations | Shlevin Harold H. | GA | D | 4 | S.dm | -1,556 | 6.02 | 0 | -258 | 31 | D | ||||||||||||||||
6/30/26 19:23 | 6/26/26 | GALT | Health | Drug | Pharmaceutical Preparations | Jamil Khurram | GA | O | Chief Me | 7 | S.dm | -1,352 | 5.03 | 0 | -269 | 4 | D | |||||||||||||||
1/6/26 16:54 | 1/2/26 | GALT | Health | Drug | Pharmaceutical Preparations | Lewis Joel | GA | DO | P,CEO | 7 | S.dm | -710 | 4.86 | 0 | -146 | 835 | D | |||||||||||||||
1/6/26 16:54 | 1/2/26 | GALT | Health | Drug | Pharmaceutical Preparations | Callicutt Jack W | GA | O | CFO | 6 | S.dm | -1,000 | 5.41 | 0 | -185 | 15 | D | |||||||||||||||
12/18/25 10:34 | 12/16/25 | GALT | Health | Drug | Pharmaceutical Preparations | 10X Fund, L.P. | GA | T | 5 | S.m | -2,434 | 5.62 | 0 | -433 | 5,872 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |